Skip to content

A clinical trial to compare the effectiveness of repeated ketamine infusions and electroconvulsive therapy in patients of depression with suicidality and how it relates to the kynurenine pathway.

Effectiveness of Repeated Ketamine Infusions on Suicidal Thoughts and Kynurenines: An Open Label Comparative Study with ECT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/035210
Enrollment
30
Registered
2021-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

Intervention1: Injection Ketamine: Injection Ketamine 0.5ml/kg body weight infusion over 40 minutes,six infusions over 2 weeks Control Intervention1: Modified Electroconvulsive Therapy: six sessions o

Sponsors

Central Institute of Psychiatry Ranchi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: â?ª Patients fulfilling ICD 10- DCR diagnostic criteria for â??unipolar(single or recurrent) non-psychotic depressive episodeâ?? â?ª Patients who are drug naïve or drug free for 2 weeks on antidepressants or 4 weeks for fluoxetine. â?ª Patients giving written informed consent â?ª Patients with suicidal ideation and behaviors are evaluated using the BSI (score>=6 has been used as a cutoff threshold for clinically significant suicidal ideation according to literature).

Exclusion criteria

Exclusion criteria: â?ª Depressive episodes with psychotic symptoms. â?ª Any other major co-morbid psychiatric diagnosis and substance dependence excluding nicotine & caffeine â?ª Presence of an acute/unstable medical or neurological condition â?ª Pregnancy or lactation

Design outcomes

Primary

MeasureTime frame
1.scores on the Becks scale of suicidal ideation following ketamine infusions vs modified electroconvulsive therapy 2.levels of kynurenine pathway metabolites kynurenic acid(KYNA) , quinolinic acid (QUIN) and QUIN/KYNA ratio in blood following ketamine infusions vs modified electroconvulsive therapy.Timepoint: 1.before 1 hour and after 1 hour, 4 hours and 24 hours of each session for six sessions and after 4 weeks of last session of ketamine infusion/modified electroconvulsive therapy. 2.one day before and after third,sixth session and four weeks of last session of ketamine infusion/modified electroconvulsive therapy.

Secondary

MeasureTime frame
1.Scores on the scales: MADRS, HAM-A, BPRS, C-SSRS, CADSS, CGI following ketamine infusions vs modified electroconvulsive therapy.Timepoint: 1.Before 1 hour and after 1 hour, 4 hours and 24 hours of each session for six sessions and after 4 weeks of last session of ketamine infusion/modified electroconvulsive therapy.

Countries

India

Contacts

Public ContactDr Varun S Mehta

Central Institute of Psychiatry, Ranchi

vs_mehta@yahoo.co.in9204858189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026